Evidence map›Paper›PMID 35924249›Full record

ArticleFrontiers in immunology2022

Oral Supplementation of

Wilawan Ruansit, Wasin Charerntantanakul

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Wilawan RuansitResearch laboratory for immunity enhancement in humans and domestic animals, Program of Biotechnology, Faculty of Science, Maejo University, Chiang Mai, Thailand.
Wasin CharerntantanakulResearch laboratory for immunity enhancement in humans and domestic animals, Program of Biotechnology, Faculty of Science, Maejo University, Chiang Mai, Thailand.
Maejo University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated the

Indexed as

HouttuyniaPorcine Reproductive and Respiratory SyndromePorcine respiratory and reproductive syndrome virusViral VaccinesAnimalsAntibodies, ViralDietary SupplementsDrugs, Chinese HerbalLeukocytes, MononuclearRNA, MessengerSwineVaccines, AttenuatedViremiaAntibodies, ViralDrugs, Chinese HerbalHouttuynia cordata extractRNA, MessengerVaccines, AttenuatedViral Vaccinescross-protectionhouttuynia cordatainterferonmodified-live virus vaccineporcine reproductive and respiratory syndrome virus

Identifiers

PMID35924249
PMCPMC9339630
OpenAlexW4285726340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.